Vanzacaftor/Tezacaftor/Deutivacaftor (D-IVA)

· Vertex Pharmaceuticals Incorporated

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Vanzacaftor/Tezacaftor/Deutivacaftor (D-IVA), covering 2025-09-26 to 2025-09-26. Get the full timeline:

Most recent: Clinical Trial Update: A Study To Evaluate the Relative Bioavailability, Food Effect, and Dose Proportionality of a Granule Formulation of Vanzacaftor/Tezacaftor/Deutivacaftor(VNZ/TEZ/D-IVA) [Phase 1]

See pricing